---
figid: PMC6143164__emss-79505-f001
figtitle: Opsin3—A Link to Visible Light-Induced Skin Pigmentation
organisms:
- NA
pmcid: PMC6143164
filename: emss-79505-f001.jpg
figlink: /pmc/articles/PMC6143164/figure/F1/
number: F1
caption: G protein-coupled receptor Opsin3 absorbs visible light of wavelength 415
  nm (≥50 J/cm2) and increases cytosolic calcium flux followed by activation and phosphorylation
  of CaMKII, CREB, ERK1/2, p38, and MITF, resulting in the expression of pigment-specific
  genes. Note that small molecules such as BAPTA (calcium chelator) or KN93 (CaMKII
  inhibitor) block the visible light-dependent opsin3 signaling. In parallel, 415
  nm (blue light) exposure results in the formation of multimeric tyrosinase (TYR)
  and tyrosinase-related protein-2/-1 (TYRP2/1) complexes. We hypothesized that activated
  ERK1/2 increases the activity of protein kinase C-β (PKC-β), which possibly phosphorylates
  the TYR and then pTYR forms the complex with TYRP1/2 on melanosomal membranes. The
  paracrine-based Kit/Kitl signaling pathway in melanocytes was shown separately.
  “?” indicates the role of these molecules or their formation/modification requires
  future investigation. CaMKII, calcium/calmodulin-dependent protein kinase II; CREB,
  CRE-binding protein; ERK, extracellular signal-regulated kinase; MITF, microphthalmia-associated
  transcription factor.
papertitle: Opsin3—A Link to Visible Light-Induced Skin Pigmentation.
reftext: Subba Rao Gangi Setty. J Invest Dermatol. 2018 Jan;138(1):13-15.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9509151
figid_alias: PMC6143164__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6143164__F1
ndex: bf8a7521-def4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6143164__emss-79505-f001.html
  '@type': Dataset
  description: G protein-coupled receptor Opsin3 absorbs visible light of wavelength
    415 nm (≥50 J/cm2) and increases cytosolic calcium flux followed by activation
    and phosphorylation of CaMKII, CREB, ERK1/2, p38, and MITF, resulting in the expression
    of pigment-specific genes. Note that small molecules such as BAPTA (calcium chelator)
    or KN93 (CaMKII inhibitor) block the visible light-dependent opsin3 signaling.
    In parallel, 415 nm (blue light) exposure results in the formation of multimeric
    tyrosinase (TYR) and tyrosinase-related protein-2/-1 (TYRP2/1) complexes. We hypothesized
    that activated ERK1/2 increases the activity of protein kinase C-β (PKC-β), which
    possibly phosphorylates the TYR and then pTYR forms the complex with TYRP1/2 on
    melanosomal membranes. The paracrine-based Kit/Kitl signaling pathway in melanocytes
    was shown separately. “?” indicates the role of these molecules or their formation/modification
    requires future investigation. CaMKII, calcium/calmodulin-dependent protein kinase
    II; CREB, CRE-binding protein; ERK, extracellular signal-regulated kinase; MITF,
    microphthalmia-associated transcription factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - blo
  - ras
  - Ras64B
  - Ras85D
  - CaMKI
  - Raf
  - Dsor1
  - Mtk
  - CrebB
  - CrebA
  - rl
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - S6kII
  - ps
  - Mitf
  - bap
  - AP-1-2beta
  - KITLG
  - KIT
  - PRKCB
  - KRAS
  - HRAS
  - NRAS
  - CAMK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPK3
  - MAPK1
  - CRK
  - MAPK14
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TP73
  - ARHGAP24
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - MITF
  - DUSP4
  - PHB2
  - SIL1
  - Ca2<<R
  - TYR
  - Cancer
  - Cardiomyopathy
  - Melanoma
  - Noonan syndrome
---
